A
Actinium Pharmaceuticals Inc
F:7AY1
Actinium Pharmaceuticals Inc
F:7AY1
Price:
0.991
EUR
1.02%
Market Closed
Market Cap:
€29.5m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Actinium Pharmaceuticals Inc
F:7AY1
|
US |
|
L
|
Linde PLC
F:LIN
|
UK |
|
I
|
International Paper Co
BMV:IP
|
US |
|
H
|
Hapag Lloyd AG
F:HLAG
|
DE |
|
I
|
Innodata Inc
F:ID6
|
US |
Wall St Price Targets
7AY1 Price Targets Summary
Actinium Pharmaceuticals Inc
Actinium Pharmaceuticals Inc
Wall Street analysts forecast 7AY1 stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for 7AY1 is 4.723 EUR with a low forecast of 1.871 EUR and a high forecast of 8.752 EUR.
Lowest Forecast
Price Target
1.871
EUR
89% Upside
Average Forecast
Price Target
4.723
EUR
377% Upside
Highest Forecast
Price Target
8.752
EUR
783% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 7AY1's stock price target?
Price Target
4.723
EUR
4.723
EUR
According to Wall Street analysts, the average 1-year price target for 7AY1 is 4.723 EUR with a low forecast of 1.871 EUR and a high forecast of 8.752 EUR.
What is the Revenue forecast for Actinium Pharmaceuticals Inc?
Projected CAGR
196%
196%
The compound annual growth rate for Revenue over the next 8 years is 196%.
